Back to 
Jacobs Levy Equity Management, Inc.
Jacobs Levy Equity Management, Inc.
TGTX
Showing 4 of 18 quarters
Position history for Jacobs Levy Equity Management, Inc.'s holdings in TG Therapeutics, Inc.
No. Jacobs Levy Equity Management exited its TGTX (TG Therapeutics) position in Q2 2025. Its Q1 2025 13F listed 85,849 shares worth $3.4M. Jacobs Levy Equity Management first reported TGTX in Q2 2019 and held it in 16 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$4.2M
Total Shares Change
-180,338
Quarter-by-Quarter History